Analyst Rates Speculative Buy, $0.61 Price Target
DALLAS, Feb. 11 /PRNewswire-FirstCall/ -- Crdentia Corp. (OTC Bulletin Board: CRDT), a leading healthcare staffing company, today announced that the independent research firm Investor Insight, an operating division of Doty-Scott Enterprises, initiated coverage on the Company. The report is available at http://www.crdentia.com/corporate/about/investor/ and through http://www.dotyscott.com and http://www.audiostocks.com.
About Crdentia Corp.
Crdentia Corp., one of the nation's leading providers of healthcare staffing solutions, is focused on recruiting talented national and international healthcare professionals to meet the ever-increasing employment needs of over 2,300 clients. Crdentia is one of the few companies that can provide quality temporary staff for all healthcare industry positions including local nurses, travel nurses, allied health, locum tenens and home care professionals. For more information, visit http://www.crdentia.com.
Forward Looking Statements
Statements contained in this release that are not historical facts are
forward-looking statements that involve risks and uncertainties. Among the
important factors which could cause actual results to differ materially
from those in the forward-looking statements include, but are not limited
to, those discussed in "Risk Factors" in the Company's Forms 10-K, Forms
10-Q, and other filings with the Securities and Exchange Commission. Such
risk factors include, but are not limited to, a limited operating history
with no earnings; reliance on the Company's management team, members of
which have other business interests; the ability to successfully implement
the Company's business plan; the ability to continue as a going concern;
the ability to fund the Company's business and acquisition strategy; the
growth of the temporary healthcare professional staffing business;
difficulty in managing operations of acquired businesses; uncertainty in
government regulation of the healthcare industry; and the limited public
market for the Company's common stock. The actual results that the Company
achieves may differ materially from any forward-looking statements due to
such risks and uncertainties. Crdentia undertakes no obligation to revise
or update publicly any forward-looking statements for any reason.
Contact Crdentia Corp.
John Kaiser, CEO
Phone: 972.850.0780
Fax: 972.392.2722
Jim TerBeest, CFO
Phone: 972.850.0780
Fax: 972.392.2722
'/>"/>
| SOURCE Crdentia Corp. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
2. Bradmer to present at the 10th Annual BIO CEO & Investor Conference
3. MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc.
4. Assurant President and Chief Executive Officer Robert B. Pollock to Present at Merrill Lynch Insurance Investor Conference on February 12
5. Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
6. Torchmark Corporation to Present at Merrill Lynch Insurance Investors Conference
7. MaxCyte to Present at the BIO CEO & Investor Conference
8. Sharps Compliance Corp. to Present at the RedChip Small-Cap Investor Conference in Scottsdale, Arizona
9. Vical to Present at BIO CEO and Investor Conference
10. ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference
11. NPS Pharmaceuticals to Present at BIO CEO & Investor Conference
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |